0
0
Home » Medical Devices » Diabetes Care Devices

Insulin Pens Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

Insulin Pens (Diabetes Care Devices) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Diabetes Care Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Insulin Pens Devices market for the year 2020 and beyond. Insulin pen is used to inject insulin for the treatment of diabetes. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose.

Insulin pens are classified into disposable and reusable insulin pens. Disposable insulin pens usually consist of pre-filled insulin cartridge which is disposed once the vial is over. In case of reusable insulin pens, the cartridge can be replaced once it is over.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are –

Currently marketed Insulin Pens Devices and evolving competitive landscape –

– Insightful review of the key industry trends.

– Annualized total Insulin Pens Devices market revenue by segment and market outlooks from 2015-2030.

– Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights –

– Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.

– SWOT analysis for Insulin Pens Devices market.

– Competitive dynamics insights and trends provided for Insulin Pens Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

– Country specific overview of the healthcare system.

– Country specific reimbursement policies.

– Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Novo Nordisk AS, Eli Lilly and Co, Sanofi, Ypsomed Holding AG

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope of the Insulin Pens (Diabetes Care Devices) market model

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Currently marketed Insulin Pens and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total insulin pens market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices, and market values by segment.
  • Global, Regional, and Country level market-specific insights include qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for insulin pens market.
  • Competitive dynamics insights and trends provided for the insulin pens market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific MedTech regulatory landscape.

What is the Insulin Pens market size during the historical and forecast period?

Insulin Pens market, by segmentFor more segment insights, download a free report sample

For more segment insights, download a free report sample

What are the key trends within the Insulin Pens market?

The North American region shares the largest market size of the insulin pens market and is expected to grow in the forecast period due to an increase in the number of the diabetic population. The highest revenue is generated in the US because of the insulin prices which is much higher than any other country because the major companies are the driver of the insulin pens revenue whereas this is not the case in other countries. Canada and Mexico have a cheaper insulin value than the US. Because of the deep device penetration and high insulin prices in the US, North America has the largest size.

The European market reflects similar trends seen in the North American space, however, has a more modest CAGR. The prevalence of diabetes is increasing among all ages in the European region, mostly due to increases in overweight and obesity, unhealthy diet, and physical inactivity. The market for insulin pens is increasing in the European region due to factors such as the availability of reimbursement of insulin pens and an increase in the diabetic population.

Asia-Pacific region has an increasing trend of government-driven price management and reimbursement controls, particularly in China and Japan. There also has been an increase in government initiatives to help local manufacturers access a bigger share of the local market. Asia-Pacific is exhibiting steady regional growth due to the presence of developing economies like India and China, Japan which have increasing healthcare expenditures. The disposable insulin pens market is increasing because of its cheaper price.

Due to increasing demand, improving healthcare infrastructures, and widening of distribution networks, the insulin pen market grows stably. High inflation rates and weakening currencies in some countries have impacted the budgets of the public healthcare systems.

Increasing investments in healthcare infrastructure and state-of-the-art medical research facilities in the Middle East & Africa will drive expanded access to insulin pens in the forecast period, along with a growing population, improvements in life expectancy, and increased awareness among both patients and physicians regarding available treatment options.

Insulin Pens market report scope

Market value (Year – 2021) $9,419 million
Segmentation Disposable Insulin Pens and Reusable Insulin Pens
Key companies Novo Nordisk AS, Eli Lilly and Co, Sanofi, Ypsomed Holding AG
Regions covered North America, South & Central America, Europe, Middle East & Africa, Asia-Pacific
Countries covered US, Canada, Mexico, France, Germany, Italy, Spain, United Kingdom, Austria, Belgium, Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Netherlands, Norway, Poland, Portugal, Russia, Sweden, Switzerland, Turkey, Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Brazil, Chile, Egypt, Israel, Saudi Arabia, South Africa, United Arab Emirates

Who are the Insulin Pens market vendors?

The model analyses the competitive landscape of the insulin pens market and includes information on the following key market vendors:

Novo Nordisk AS, Eli Lilly and Co, Sanofi, Ypsomed Holding AG.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –

– CMO executives who must have deep understanding of the Insulin Pens marketplace to make strategic planning and investment decisions.

– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

-Understand the impact of COVID-19 on Insulin Pens market.

-Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

-Develop business strategies by understanding the trends shaping and driving Insulin Pens market.

-Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Insulin Pens market in the future.

-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

-Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

-Track device sales in the global and country-specific Insulin Pens market from 2015-2030.

-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Key Players

Novo Nordisk AS

Eli Lilly and Co

Sanofi

Ypsomed Holding AG

Others

Frequently Asked Questions

The insulin pens market in 2021 is worth $9,419 million.

The insulin pens market has been segmented by product (Disposable Insulin Pens and Reusable Insulin Pens), and by 5 regions (North America, South & Central America, Europe, Middle East & Africa and Asia-Pacific).

Key players in the insulin pens market are Novo Nordisk AS, Eli Lilly and Co, Sanofi, and Ypsomed Holding AG.

The reusable insulin pens segment has the largest share in the global insulin pens market.

Novo Nordisk AS has the largest market share in the insulin pens market.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports